SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS

The present invention relates to novel sulfone compounds as 5-HT6 receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present inv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MULLA, MOHAMAD SADIK ABDULHAMID, BADANGE, RAJESH KUMAR, CHINDHE, ANIL KASHINATH, JASTI, VENKATESWARLU, REBALLI, VEENA, NIROGI, RAMAKRISHNA, AHMAD, ISHTIYAQUE, ABRAHAM, RENNY, SHINDE, ANIL KARBHARI, KAMBHAMPATI, RAMA SASTRI, NAMALA, RAMBABU
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MULLA, MOHAMAD SADIK ABDULHAMID
BADANGE, RAJESH KUMAR
CHINDHE, ANIL KASHINATH
JASTI, VENKATESWARLU
REBALLI, VEENA
NIROGI, RAMAKRISHNA
AHMAD, ISHTIYAQUE
ABRAHAM, RENNY
SHINDE, ANIL KARBHARI
KAMBHAMPATI, RAMA SASTRI
NAMALA, RAMBABU
description The present invention relates to novel sulfone compounds as 5-HT6 receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment/prevention of various disorders that are related to 5-HT6 receptor functions. La présente invention concerne de nouveaux composés sulfones en tant que ligands du récepteur 5-HT6, représentés par la formule (I), et leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. La présente invention porte également sur un procédé de préparation desdits nouveaux composés ci-dessus et de leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. Ces composés sont utiles dans le traitement/la prévention de divers troubles qui sont liés aux fonctions du récepteur 5-HT6.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2786072C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2786072C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2786072C3</originalsourceid><addsrcrecordid>eNrjZNAODvVx8_dzVXD29w3wD_VzCVZwDFYw1fUIMVMIcnV2DQjxD1Lw8XR3BMrwMLCmJeYUp_JCaW4GeTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0cjcwszA3MjZ2PCKgDTgyPa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS</title><source>esp@cenet</source><creator>MULLA, MOHAMAD SADIK ABDULHAMID ; BADANGE, RAJESH KUMAR ; CHINDHE, ANIL KASHINATH ; JASTI, VENKATESWARLU ; REBALLI, VEENA ; NIROGI, RAMAKRISHNA ; AHMAD, ISHTIYAQUE ; ABRAHAM, RENNY ; SHINDE, ANIL KARBHARI ; KAMBHAMPATI, RAMA SASTRI ; NAMALA, RAMBABU</creator><creatorcontrib>MULLA, MOHAMAD SADIK ABDULHAMID ; BADANGE, RAJESH KUMAR ; CHINDHE, ANIL KASHINATH ; JASTI, VENKATESWARLU ; REBALLI, VEENA ; NIROGI, RAMAKRISHNA ; AHMAD, ISHTIYAQUE ; ABRAHAM, RENNY ; SHINDE, ANIL KARBHARI ; KAMBHAMPATI, RAMA SASTRI ; NAMALA, RAMBABU</creatorcontrib><description>The present invention relates to novel sulfone compounds as 5-HT6 receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment/prevention of various disorders that are related to 5-HT6 receptor functions. La présente invention concerne de nouveaux composés sulfones en tant que ligands du récepteur 5-HT6, représentés par la formule (I), et leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. La présente invention porte également sur un procédé de préparation desdits nouveaux composés ci-dessus et de leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. Ces composés sont utiles dans le traitement/la prévention de divers troubles qui sont liés aux fonctions du récepteur 5-HT6.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141028&amp;DB=EPODOC&amp;CC=CA&amp;NR=2786072C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20141028&amp;DB=EPODOC&amp;CC=CA&amp;NR=2786072C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MULLA, MOHAMAD SADIK ABDULHAMID</creatorcontrib><creatorcontrib>BADANGE, RAJESH KUMAR</creatorcontrib><creatorcontrib>CHINDHE, ANIL KASHINATH</creatorcontrib><creatorcontrib>JASTI, VENKATESWARLU</creatorcontrib><creatorcontrib>REBALLI, VEENA</creatorcontrib><creatorcontrib>NIROGI, RAMAKRISHNA</creatorcontrib><creatorcontrib>AHMAD, ISHTIYAQUE</creatorcontrib><creatorcontrib>ABRAHAM, RENNY</creatorcontrib><creatorcontrib>SHINDE, ANIL KARBHARI</creatorcontrib><creatorcontrib>KAMBHAMPATI, RAMA SASTRI</creatorcontrib><creatorcontrib>NAMALA, RAMBABU</creatorcontrib><title>SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS</title><description>The present invention relates to novel sulfone compounds as 5-HT6 receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment/prevention of various disorders that are related to 5-HT6 receptor functions. La présente invention concerne de nouveaux composés sulfones en tant que ligands du récepteur 5-HT6, représentés par la formule (I), et leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. La présente invention porte également sur un procédé de préparation desdits nouveaux composés ci-dessus et de leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. Ces composés sont utiles dans le traitement/la prévention de divers troubles qui sont liés aux fonctions du récepteur 5-HT6.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAODvVx8_dzVXD29w3wD_VzCVZwDFYw1fUIMVMIcnV2DQjxD1Lw8XR3BMrwMLCmJeYUp_JCaW4GeTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0cjcwszA3MjZ2PCKgDTgyPa</recordid><startdate>20141028</startdate><enddate>20141028</enddate><creator>MULLA, MOHAMAD SADIK ABDULHAMID</creator><creator>BADANGE, RAJESH KUMAR</creator><creator>CHINDHE, ANIL KASHINATH</creator><creator>JASTI, VENKATESWARLU</creator><creator>REBALLI, VEENA</creator><creator>NIROGI, RAMAKRISHNA</creator><creator>AHMAD, ISHTIYAQUE</creator><creator>ABRAHAM, RENNY</creator><creator>SHINDE, ANIL KARBHARI</creator><creator>KAMBHAMPATI, RAMA SASTRI</creator><creator>NAMALA, RAMBABU</creator><scope>EVB</scope></search><sort><creationdate>20141028</creationdate><title>SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS</title><author>MULLA, MOHAMAD SADIK ABDULHAMID ; BADANGE, RAJESH KUMAR ; CHINDHE, ANIL KASHINATH ; JASTI, VENKATESWARLU ; REBALLI, VEENA ; NIROGI, RAMAKRISHNA ; AHMAD, ISHTIYAQUE ; ABRAHAM, RENNY ; SHINDE, ANIL KARBHARI ; KAMBHAMPATI, RAMA SASTRI ; NAMALA, RAMBABU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2786072C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MULLA, MOHAMAD SADIK ABDULHAMID</creatorcontrib><creatorcontrib>BADANGE, RAJESH KUMAR</creatorcontrib><creatorcontrib>CHINDHE, ANIL KASHINATH</creatorcontrib><creatorcontrib>JASTI, VENKATESWARLU</creatorcontrib><creatorcontrib>REBALLI, VEENA</creatorcontrib><creatorcontrib>NIROGI, RAMAKRISHNA</creatorcontrib><creatorcontrib>AHMAD, ISHTIYAQUE</creatorcontrib><creatorcontrib>ABRAHAM, RENNY</creatorcontrib><creatorcontrib>SHINDE, ANIL KARBHARI</creatorcontrib><creatorcontrib>KAMBHAMPATI, RAMA SASTRI</creatorcontrib><creatorcontrib>NAMALA, RAMBABU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MULLA, MOHAMAD SADIK ABDULHAMID</au><au>BADANGE, RAJESH KUMAR</au><au>CHINDHE, ANIL KASHINATH</au><au>JASTI, VENKATESWARLU</au><au>REBALLI, VEENA</au><au>NIROGI, RAMAKRISHNA</au><au>AHMAD, ISHTIYAQUE</au><au>ABRAHAM, RENNY</au><au>SHINDE, ANIL KARBHARI</au><au>KAMBHAMPATI, RAMA SASTRI</au><au>NAMALA, RAMBABU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS</title><date>2014-10-28</date><risdate>2014</risdate><abstract>The present invention relates to novel sulfone compounds as 5-HT6 receptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment/prevention of various disorders that are related to 5-HT6 receptor functions. La présente invention concerne de nouveaux composés sulfones en tant que ligands du récepteur 5-HT6, représentés par la formule (I), et leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. La présente invention porte également sur un procédé de préparation desdits nouveaux composés ci-dessus et de leurs dérivés, promédicaments, tautomères, stéréo-isomères, polymorphes, solvates, hydrates, métabolites, N-oxydes et sels de qualité pharmaceutique, ainsi que des compositions les contenant. Ces composés sont utiles dans le traitement/la prévention de divers troubles qui sont liés aux fonctions du récepteur 5-HT6.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2786072C
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T01%3A16%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MULLA,%20MOHAMAD%20SADIK%20ABDULHAMID&rft.date=2014-10-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2786072C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true